Show
Sort by
-
Prognostic significance of blasts with/without pleiocytosis in the cerebro-spinal fluid (CSF) of children with acute lymphoblastic leukemia (ALL) treated without cranial irradiation: results of European Organization for Research and Treatment of Cancer (EORTC) children leukemia group study 58881
-
Results of 58872 and 58921 trials in acute myeloblastic leukemia and relative value of chemotherapy vs allogeneic bone marrow transplantation in first complete remission: the EORTC Children Leukemia Group report
-
Treatment outcome in infant acute lymphoblastic leukemia.
-
Long-term results of three randomized trials (58831,58832,58881) in childhood acute lymphoblastic leukemia: a CLCG-EORTC report.
-
Cutaneous involvement in children with acute lymphoblastic leukemia or lymphoblastic lymphoma
-
Mitoxantrone-containing regimen for treatment of childhood acute leukemia (AML) and analysis of prognostic factors : results of the EORTC Children Leukemia Cooperative Study 58872
-
Juvenile myelomonocytic leukemia: Analyses of treatment results in the EORTC Children's Leukemia Cooperative Group (CLCG)
-
Specific cutaneous infiltrates in children with acute lymphoblastic leukemia or lymphoblastic lymphoma
-
Improved survival for acute lymphoblastic leukaemia in infancy: the experience of EORTC-childhood Leukemia Cooperative Group.
-
CSF drug levels for children with acute lymphoblastic leukemia treated by 5 g/m² methotrexate: a study from the EORTC Childrens' Leukemia Cooperative Group